1 ge, as a critical global concern, has fueled
our efforts to address it through different strategies.
2 We report
our efforts to address these challenges, with the goal o
3 In
our efforts to address this issue, we generated a panel
4 In this paper, we describe
our efforts to apply a wide variety of standard, photo-,
5 This was a remarkable achievement in
our efforts to appreciate how the aberrant function of R
6 ve to neuroimaging technologies and enhances
our efforts to assess the impact of chemical exposures o
7 bserved and also reflect on what has allowed
our efforts to be both successful and sustainable.
8 sed, it remains largely untested, motivating
our efforts to benchmark pI prediction methods.
9 ies, Anthoceros agrestis, is instrumental in
our efforts to better understand not only hornwort biolo
10 Studies employing BA14K should contribute to
our efforts to better understand the antigenic specifici
11 o conduct data mining workflows, and discuss
our efforts to build a robust and scalable architecture
12 ems with the proposed secondary structure in
our efforts to build a three-dimensional model that is c
13 As part of
our effort to characterize the Ap4A receptor building do
14 In
our effort to characterize the signal-transduction pathw
15 In
our effort to characterize three nucleotide mutations of
16 In
our efforts to characterize downstream mediators of CD40
17 We here report
our efforts to characterize electric resistances in a CD
18 As part of
our efforts to characterize more fully the structural fe
19 he results of mutagenesis studies as well as
our efforts to characterize the initial steps of the PAD
20 During
our efforts to characterize the regulatory properties of
21 ons in immunocompromised patients, underline
our efforts to characterize viral immunoevasins, such as
22 Our efforts to clarify these relationships have revealed
23 During
our efforts to clone this gene we also isolated a phage
24 Even
our efforts to combine replicating compartments and gene
25 ve transformations of hydrocarbons, prompted
our efforts to conduct an in-depth investigation of a ra
26 In this review, we describe
our efforts to create a form of gene-targeted radiation
27 We report on
our efforts to create an on-chip system to simultaneousl
28 aining side chain was recently identified in
our efforts to create novel antidepressants that act as
29 In
our efforts to define a cancer dependency map, we perfor
30 Our efforts to define molecular correlates of SVC112 sen
31 In
our efforts to define the genes overexpressed in carcino
32 In
our efforts to define the specific mechanisms for bacter
33 In
our efforts to define the structural elements required f
34 Our efforts to delineate these pathways in primary murin
35 s, it is imperative to continue and increase
our efforts to describe genomic risk in and across Afric
36 As part of
our effort to design novel inhibitors of ROCK, we invest
37 onary races of virus and antibody may impact
our efforts to design a universal influenza vaccine.
38 l hierarchy of enamel and that contribute to
our efforts to design and develop enamel biomimetic mate
39 Here we report
our efforts to design and discover a new series of tunab
40 As a part of
our efforts to design prodrugs for antiviral nucleosides
41 In
our efforts to design selective histone deactylase inhib
42 We report here
our efforts to determine direct antitumor effects of tha
43 As part of
our efforts to determine the molecular details of the ro
44 In
our effort to develop a pharmacotherapy for the treatmen
45 In
our effort to develop agents for the treatment of influe
46 of the many lessons that we have learned in
our effort to develop experimental treatments for Hutchi
47 In
our effort to develop FR-targeted SMDCs with varying mec
48 In
our effort to develop high-affinity ligands for the dopa
49 In
our effort to develop more potent, less neurotoxic agent
50 In
our effort to develop multifunctional compounds that cot
51 In
our effort to develop multifunctional drugs against Park
52 In
our effort to develop selective sphingosine kinase-2 (Sp
53 Herein we report
our efforts to develop a continuous flow methodology for
54 In
our efforts to develop a disease-modifying osteoarthriti
55 nefits of increasing body coverage, describe
our efforts to develop a first-generation total-body PET
56 xt of a PRMT5 inhibitor program, we describe
our efforts to develop a flexible and robust strategy to
57 We have been successful in
our efforts to develop a long lived noncytolytic murine
58 Here, we describe
our efforts to develop a selective SRC covalent inhibito
59 chemical and biophysical assays, we describe
our efforts to develop acyclic scaffold-hops from GSK-69
60 ploration of therapeutic options, we focused
our efforts to develop an Ex Vivo Tumor platform to cult
61 investigate these mechanisms, specifically,
our efforts to develop and validate aptamers containing
62 ent that could actually mislead or misdirect
our efforts to develop better diagnostic tools and more
63 As part of
our efforts to develop CB2 PET imaging agents, we invest
64 ypes that comprise the nervous system and in
our efforts to develop cellular models of disease that r
65 s combination and discuss its importance for
our efforts to develop climate change-resilient crops.
66 ns underlying neurodegeneration will enhance
our efforts to develop effective therapeutic approaches
67 As part of
our efforts to develop effective WNV inhibitors, we reex
68 These explorations will inform
our efforts to develop highly effective and robust organ
69 Herein, we report on
our efforts to develop in vitro assays to reliably ident
70 In this study, we have continued
our efforts to develop isoxazole-based anti-TB compounds
71 rd for future immunotherapies and will guide
our efforts to develop more efficacious and less toxic i
72 As part of
our efforts to develop nanoparticles with novel optical
73 Since then, we have continued
our efforts to develop new and improved database tools t
74 Here, we detail
our efforts to develop noncovalent, macrocyclic peptide
75 e recently reported a preliminary account of
our efforts to develop novel diarylamine radical-trappin
76 e recently reported a preliminary account of
our efforts to develop novel diarylamine radical-trappin
77 In
our efforts to develop novel nNOS inhibitors for the tre
78 In
our efforts to develop novel small molecule NLRP3 inhibi
79 In
our efforts to develop oncolytic peptides, we identified
80 In
our efforts to develop orally active GPIIb-IIIa antagoni
81 As part of
our efforts to develop peptide-based hydrogel materials
82 In
our efforts to develop photoswitchable antibiotics, we i
83 In
our efforts to develop potent and selective antagonists
84 As part of
our efforts to develop rhenium-oxo corroles as photosens
85 bioisosteres represent an important step in
our efforts to develop stable, bioavailable, and selecti
86 As part of
our efforts to develop synthetic access to this family,
87 In this study, we continued
our efforts to develop triazol-4-ylphenyl bearing hydrox
88 Here, we summarize
our efforts to devise and employ diverse imaging tools t
89 In
our effort to discover DPP-4 inhibitors with added benef
90 In
our effort to discover potent and specific inhibitors of
91 Here, we describe
our efforts to discover a novel series of selective PI3K
92 As a continuation of
our efforts to discover and develop the apoptosis-induci
93 Herein, we describe
our efforts to discover highly potent, partial agonists
94 In
our efforts to discover neuronal isoform selective nitri
95 In
our efforts to discover novel and truly selective nAChR
96 As a result of
our efforts to discover novel p53:MDM2 protein-protein i
97 Here we describe
our efforts to discover novel, highly potent inhaled inh
98 In the course of
our efforts to discover potent inhibitors of Bcl-2 famil
99 Our efforts to discover potent, orally bioavailable type
100 As part of
our effort to dissect the mechanism(s) underlying induct
101 results place the mosquito at the centre of
our efforts to dissect mechanisms of protective immunity
102 Here we extend
our efforts to dissect the mechanism of inhibition and s
103 rofession to regulate its own practices, but
our efforts to do so have been uneven.
104 ubjects generate such antibodies will assist
our efforts to elicit bNAbs by immunization.
105 in the Escherichia coli system has hindered
our efforts to elucidate its structure and function.
106 Our efforts to elucidate potential mechanism(s) for this
107 In
our efforts to elucidate the interaction between Cdc25B
108 Herein we describe
our efforts to elucidate the key mechanistic aspects of
109 Here we report the results of
our efforts to elucidate the mechanism of regulation of
110 Our efforts to elucidate the molecular events in the ear
111 We report
our efforts to enable transition-metal catalysis in the
112 lly consider the method of administration in
our efforts to engage specific central oxytocinergic tar
113 To address these challenges, we report on
our efforts to engineer a (monovalent) single-chain dime
114 tively predicting biological behavior hinder
our efforts to engineer biological systems to produce bi
115 In this work, we describe
our efforts to engineer complex riboswitches capable of
116 the temperate Burkholderia phage Milagro and
our efforts to engineer this phage into a potential ther
117 In
our effort to enhance its solubility by using natural me
118 Herein, we report
our efforts to enhance the pharmacological profile of ou
119 As part of
our efforts to evaluate the role of sialic acid in the p
120 This requirement catalyzed
our efforts to evolve MS-grade mutant PTM-directed prote
121 As part of
our efforts to expand the genetic alphabet, we have deve
122 In
our efforts to expand this small family of phases, LaScS
123 In
our effort to explain this effect, we have begun to meas
124 Our efforts to explain this unexpected result led to the
125 In
our efforts to explore marine cyanobacteria as a source
126 In
our efforts to explore the biology of the male reproduct
127 ths, metastasis is the ultimate challenge in
our effort to fight cancer as a life-threatening disease
128 In
our effort to find diagnostic markers and to develop the
129 In
our effort to find small-molecule treatments of advanced
130 In continuation of
our efforts to find highly potent activators of PKC for
131 ed understanding of voluntarism will help in
our efforts to fulfill the principle of respect for pers
132 Here we describe
our efforts to fully characterize the cellular localizat
133 In
our efforts to further characterize this unusual mode of
134 In
our efforts to further explore their antiviral activitie
135 In
our efforts to further explore this direction, we have u
136 This article reports
our efforts to further improve a single-method fold reco
137 In
our efforts to further optimize the compound class, we h
138 In this paper we report
our efforts to further optimize the selectivity profile
139 Herein, we report
our efforts to further understanding of the functions th
140 Here we summarize
our efforts to further validate ChoKalpha as an oncogeni
141 In
our effort to gain further insight into the enantioselec
142 These models form part of
our effort to generate an anatomic framework of Drosophi
143 As part of
our effort to generate better analogs of rifamycin, we s
144 In this work, we continued
our effort to generate new, potent, nontoxic, and multip
145 In
our efforts to generate a new medicine for liver fibrosi
146 ibrosis, and that FZHY treatment can enhance
our efforts to generate mature hepatocytes with prolifer
147 an endanger the individual, our society, and
our efforts to handle the disease.
148 most of the major treatment modalities, yet
our efforts to harness this knowledge to improve therape
149 ormation-related Ag, which was the result of
our effort to identify an antigenically distinct tumor A
150 In
our effort to identify CRF(1) antagonists with improved
151 In
our effort to identify G protein coupling domains of the
152 In
our effort to identify inhibitors of the HIF-1 activatio
153 Our effort to identify novel drug-resistant genes in cyc
154 In
our effort to identify structural and functional homolog
155 This report outlines
our efforts to identify a compound suitable for once dai
156 In
our efforts to identify a myeloid tumor suppressor gene
157 Herein, we report
our efforts to identify a novel chemotype as one strateg
158 Here we describe
our efforts to identify a potent, selective, and G prote
159 We describe herein
our efforts to identify a selective neutral endopeptidas
160 Our efforts to identify additional endogenous direct tar
161 In this paper, we describe
our efforts to identify an additional interaction and a
162 In
our efforts to identify cellular DNA repair proteins req
163 Herein we describe in more detail
our efforts to identify FB inhibitors by high-throughput
164 In
our efforts to identify genes that participate in this p
165 In
our efforts to identify IFN-induced cellular proteins th
166 ge of an opportune byproduct obtained during
our efforts to identify IRAK4 inhibitors, we identified
167 In
our efforts to identify molecules that might act as coca
168 In
our efforts to identify novel chemical scaffolds for the
169 In
our efforts to identify novel chemical scaffolds for the
170 In
our efforts to identify novel galectin-3 disaccharide mi
171 Our efforts to identify novel Na(+),K(+)-ATPase binding
172 Here we describe
our efforts to identify novel proteins using a phage-dis
173 In
our efforts to identify novel small molecule inhibitors
174 Subsequently, we extended
our efforts to identify PI3Kalpha-specific inhibitors us
175 Our efforts to identify potent, efficacious, and orally
176 Our efforts to identify potent, selective FabI inhibitor
177 Herein, we disclose
our efforts to identify potent, selective, and orally bi
178 Our efforts to identify potent, selective, and pharmaceu
179 Herein, we describe
our efforts to identify reversible inhibitors of LSD1 fr
180 In continuing
our efforts to identify small molecules able to disrupt
181 Although successful,
our efforts to identify superior combinations of growth-
182 In the current study, we focused
our efforts to identify the BMD candidate gene in chromo
183 dient dialysis has allowed a breakthrough in
our efforts to identify the nucleosomal locations of the
184 In
our efforts to identify the protein components of the ce
185 In
our efforts to identify the residue at which this radica
186 Herein, we report
our efforts to identify the steric and leaving group req
187 lack of molecular understanding complicates
our efforts to identify therapeutic compounds or strateg
188 It is of vital importance that we renew
our efforts to identify, evaluate and treat all patients
189 mapping study has been unexplored, hampering
our effort to illustrate the detailed genetic architectu
190 As cardiologists, we should increase
our efforts to improve coverage, quality, and cost, both
191 How can we maximize the present value of
our efforts to improve diagnostic imaging?
192 r understanding of human biology and advance
our efforts to improve health.
193 Here, we will discuss
our efforts to improve the clinical care of patients wit
194 Here we report on the results of
our efforts to improve the MWM method's predictive accur
195 We also report on
our efforts to improve the oral bioavailability and phar
196 In the present work, we describe
our efforts to improve the performance of one of the ear
197 We report herein
our efforts to improve their pharmacokinetic properties
198 We now report
our efforts to improve this vaccine by screening a subli
199 Herein, we describe
our efforts to inhibit the essential A. baumannii lipool
200 As part of
our effort to investigate the structure-transfection eff
201 In
our efforts to investigate the role of the cytoplasmic D
202 This has focused
our efforts to isolate genes required for newborn respir
203 immunosuppressive drugs; and (iii) describe
our efforts to make new less-immunogenic RITs by identif
204 In this paper we report the results of
our efforts to map the genes responsible for resistance
205 We report here
our efforts to measure the crawling force generated by c
206 sses by which N2O is produced is critical to
our efforts to mitigate climate change.
207 sources, which can result in biases-despite
our efforts to mitigate them-related to the methodologic
208 Here we describe
our efforts to more precisely define the role of sbyA an
209 In
our effort to obtain a thorough genotype, we have analyz
210 In
our efforts to obtain atomic information on microtubule-
211 In
our efforts to obtain electrocatalysts with improved act
212 As part of
our effort to optimize conditions for evaluating VR1 pha
213 In continuation of
our effort to optimize the pharmacological profile of [1
214 Here, we describe
our efforts to optimize 1.
215 ent success in this area, we describe herein
our efforts to optimize a novel purine carboxylic acid-d
216 We now report
our efforts to optimize quinolon-4(1H)-imines as dual-st
217 agonists is described herein as we continue
our efforts to optimize the 2-phenylcyclopropylmethylami
218 Herein we report
our efforts to optimize the MMP-13 potency and pharmacok
219 In the work described here, we report on
our efforts to optimize the sensitivity of SUPREX analys
220 Here we describe
our effort to overcome this limitation, the PSC-SCR, a r
221 It is imperative that we increase
our efforts to prepare for the unique challenges that we
222 Herein, we detail
our efforts to prepare these molecules by chemical synth
223 Herein, we make
our efforts to present a comprehensive review on the lat
224 In
our efforts to produce monoclonal antibodies that recogn
225 As part of
our efforts to produce neuroprosthetic devices and to fu
226 In
our efforts to protect patient privacy, however, we shou
227 he data represent an important first step in
our efforts to provide genetically improved crickets for
228 As a part of
our efforts to pursue direct, convergent, and concise me
229 selectivity remains limited, thus hindering
our efforts to rationally re-engineer PKSs.
230 It is thus essential to redouble
our efforts to reach the goal of placing 15 million peop
231 Our efforts to reconstitute pitcher fluid activity using
232 ng, and after endosymbioses further confound
our efforts to reconstruct the ancient mergers that forg
233 Therefore, we here describe
our efforts to reconstruct the phylogeny of all availabl
234 comprehensive genomic resources and describe
our efforts to reduce genome redundancy in our Bacteria
235 nd worldwide rapid transportation complicate
our efforts to reduce the impact of LRI disease in child
236 As part of
our efforts to relate anti-DNA affinity and specificity
237 However,
our efforts to replicate this experiment were confounded
238 more, we will describe how we have increased
our efforts to reuse, reanalyze and disseminate high-qua
239 Our efforts to reveal how Cobl is physically and functio
240 state of the 3D chromatin field and discuss
our efforts to run and validate the models.
241 In
our efforts to scan the mRNA-displayed proteome librarie
242 [reactions: see text] In
our effort to search for carbonyl reductases with anti-P
243 In
our effort to search for key regulators in the plant vac
244 Here, we discuss
our efforts to simplify the bicyclohexane fused thiophen
245 tion of multivalent compounds is critical to
our efforts to study and interface with biological syste
246 We report
our efforts to study host-guest complexes in the gas pha
247 , we generated mt-Keima Drosophila to extend
our efforts to study mitophagy in vivo.
248 Here, we describe
our efforts to study TCDS in E.coli using a newly develo
249 In
our efforts to study the binding of the beta(')-subunit
250 During
our efforts to study this pathway, we identified HBD2 (h
251 Our efforts to suppress TNF-alpha have centered on the i
252 Here, we report
our efforts to tap the potential of understudied GPCRs b
253 During the course of
our efforts to target intracellular protein-protein inte
254 As part of
our efforts to target the 5-HT6 receptor, new benzimidaz
255 The present study is part of
our effort to test the hypothesis that each glomerulus i
256 efficiencies of nuclear transfer we directed
our efforts to the introduction of specific genetic chan
257 We recently reported
our efforts to tune the selectivity of these inhibitors
258 In
our efforts to uncover the metabolic pathways that contr
259 In
our efforts to uncover trade routes of trafficked sea tu
260 In
our effort to understand genetic disorders of the photor
261 As part of
our effort to understand how Elongin C regulates the act
262 As part of
our effort to understand how the Elongin BC complex regu
263 Network analysis has an increasing role in
our effort to understand the complexity of biological sy
264 As part of
our effort to understand the functions of Elongin BC-bas
265 As part of
our effort to understand the molecular and physiological
266 In
our effort to understand the molecular basis of this int
267 single P-element insertions will facilitate
our effort to understand the structural and functional p
268 Here, we briefly review
our effort to understand the structural organization of
269 In
our effort to understand the transcriptional regulation
270 man age-related nondisjunction, complicating
our efforts to understand - and, ultimately, to provide
271 In the current paper, we wish to report
our efforts to understand and improve the poor PK in non
272 This insight is invaluable to
our efforts to understand and subsequently design sequen
273 ic behavior in silico is an integral part of
our efforts to understand biology.
274 ein profiling) has become a key component in
our efforts to understand complex biological processes.
275 eritance are an emerging area of interest in
our efforts to understand fetal alcohol spectrum disorde
276 Herein, we describe
our efforts to understand how to co-optimize human and m
277 Like the immune response itself,
our efforts to understand the "rules" for self-nonself d
278 In
our efforts to understand the consequences of replacing
279 s paper represents the latest development in
our efforts to understand the Earth's biodiversity at th
280 Our efforts to understand the function of sensory system
281 This study is a continuation of
our efforts to understand the interplay in the self-asse
282 We describe
our efforts to understand the key mechanistic aspects of
283 In
our efforts to understand the mechanism of a drug-resist
284 In
our efforts to understand the molecular genetic basis of
285 In
our efforts to understand the physiology of recovery, we
286 In
our efforts to understand the role of gamma-tubulin in c
287 In
our efforts to understand the role of pathway in affecti
288 ilic airway inflammation in a mouse model in
our efforts to understand the underlying mechanisms.
289 ailable data suggest that we should increase
our efforts to understand the virology and pathogenesis
290 In
our efforts to understand their synthesis, chemical comp
291 Our efforts to understand why DinB (DNA polymerase IV) o
292 widespread devastation, we need to increase
our efforts to understanding the physiological and metab
293 As an initial step in
our efforts to unify the expression of peptide retention
294 most cell types, it would greatly facilitate
our effort to unravel transcriptional regulatory network
295 This study presents
our efforts to unravel the complexity of the interactome
296 Here, we describe
our efforts to use artificial intelligence (AI)-based im
297 As part of
our efforts to use NMR techniques to assist in decipheri
298 he study presented here is a continuation of
our efforts to use the X-ray structure of the T. foetus
299 The current study is a continuation of
our efforts to use the X-ray structures of T. brucei and
300 We also describe
our efforts to validate GeneScription through its evalua